-transparent.png){kind=logo}
Transforming growth factor (TGF)-alpha, epidermal growth factor (EGF), and insulin-like growth factor-1 (IGF-1) addition to quiescent, confluent monolayers of rabbit renal proximal tubule cells in primary culture stimulated [3H]thymidine incorporation. TGF-alpha and EGF promoted a 14-fold rise in thymidine incorporation over control levels with half-maximal responses at 2 x 10(-9) M. IGF-1 only promoted a 4-fold rise in thymidine incorporation compared with control values with a half-maximal response of 10(-8) M. Platelet-derived growth factor alone did not stimulate [3H]thymidine incorporation and did not potentiate the effects of EGF or IGF-1 on DNA synthesis, suggesting that platelet-derived growth factor is neither a competence nor a progression growth factor for renal proximal tubule cells. TGF-beta inhibited both baseline and EGF-stimulated [3H]thymidine incorporation after 48 hours of exposure but enhanced EGF-stimulated DNA synthesis at 24 hours. Morphologic evaluation with phase contrast microscopy, scanning, and transmission electron microscopy demonstrated that TGF-beta promoted a dramatic phenotypic transformation of the epithelial monolayer with migration and adhesion of the cells to form solid clusters of adherent cells. Quantitative morphometry demonstrated that this transformation developed 24 hours after TGF-beta exposure, was nearing completion after 48 hours of TGF-beta treatment, and correlated to TGF-beta related inhibition of EGF-induced DNA synthesis (r = -0.82, p less than 0.01). These results demonstrate that EGF and TGF-alpha are the most potent growth promoters for renal proximal tubule cells. IGF-1 is only a modest growth promoter, whereas platelet-derived growth factor has no effect either as a competence or progressive growth factor. TGF-beta inhibited EGF-induced DNA synthesis but only after observable phenotypic transformation of the cells. The degree of TGF-beta promoted transformation on renal tubule cells was highly correlative to th e antiproliferative effect of TGF-beta, suggesting that similar molecular components which promote this phenotypic transformation may also be critical in the antiproliferative effect of TGF-beta.
H D Humes, and
T F Beals, and
D A Cieslinski, and
I O Sanchez, and
T P Page
March 1994,
The American journal of physiology,
H D Humes, and
T F Beals, and
D A Cieslinski, and
I O Sanchez, and
T P Page
January 1996,
Life sciences,
H D Humes, and
T F Beals, and
D A Cieslinski, and
I O Sanchez, and
T P Page
November 2007,
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
H D Humes, and
T F Beals, and
D A Cieslinski, and
I O Sanchez, and
T P Page
November 1997,
The Journal of laboratory and clinical medicine,
H D Humes, and
T F Beals, and
D A Cieslinski, and
I O Sanchez, and
T P Page
October 1996,
Bioscience reports,
H D Humes, and
T F Beals, and
D A Cieslinski, and
I O Sanchez, and
T P Page
October 2020,
Tissue engineering. Part A,
H D Humes, and
T F Beals, and
D A Cieslinski, and
I O Sanchez, and
T P Page
December 2002,
Kidney international,
H D Humes, and
T F Beals, and
D A Cieslinski, and
I O Sanchez, and
T P Page
January 1989,
Cancer communications,
H D Humes, and
T F Beals, and
D A Cieslinski, and
I O Sanchez, and
T P Page
September 2007,
The American journal of pathology,
H D Humes, and
T F Beals, and
D A Cieslinski, and
I O Sanchez, and
T P Page
January 1996,
Journal of biochemical toxicology,
